Suppr超能文献

在液基涂片上进行DNA倍体测量的实用性,这些涂片在细胞学和高危型人乳头瘤病毒分型之间显示出相互矛盾的结果。

Usefulness of DNA ploidy measurement on liquid-based smears showing conflicting results between cytology and high-risk human papillomavirus typing.

作者信息

Lorenzato Marianne, Bory Jean-Paul, Cucherousset Jöel, Nou Jean-Marie, Bouttens Dominique, Thil Corinne, Dez Francine, Evrard Ghislaine, Quereux Christian, Birembaut Philippe, Clavel Christine

机构信息

Laboratory Pol Bouin, CHU Maison Blanche, Reims, France.

出版信息

Am J Clin Pathol. 2002 Nov;118(5):708-13. doi: 10.1309/6NXC-V9XD-YM87-8FAE.

Abstract

To improve the positive predictive value (PPV) for high-risk human papillomavirus (HR-HPV) in primary screening, DNA ploidy was measured on the same liquid-based sample by image cytometry in 984 cases showing discrepancies between cytology and HR-HPV testing. Of the conflicting results, 14.5% corresponded to a cytologic lesion (from atypical squamous cells of undetermined significance to high-grade squamous intraepithelial lesion [HSIL]) without HPV detected, and 85.5% of smears were within normal limits but revealed an HR-HPV infection. A suspect DNA profile was associated significantly with a lesion. In 497 patients who underwent repeated HPV testing, a normal DNA profile at the first smear predicted the clearance of HPV infection (sensitivity, 81.5%; specificity, 45.4%; PPV, 69%; negative predictive value, 62.4%). In persistent HR-HPV infection, a suspect DNA profile at the first smear increased the PPVfrom 10.8% to 22.7% for the detection of a histologically proven HSIL with a sensitivity of 95.2%. DNA ploidy can be used to select smears with high risk of HSIL, especially in cases of persistent HR-HPV infection.

摘要

为提高初筛中高危型人乳头瘤病毒(HR-HPV)的阳性预测值(PPV),对984例细胞学检查与HR-HPV检测结果不一致的病例,采用图像细胞术在同一液基样本上检测DNA倍体。在相互矛盾的结果中,14.5%对应于未检测到HPV的细胞学病变(从意义不明确的非典型鳞状细胞到高级别鳞状上皮内病变[HSIL]),85.5%的涂片在正常范围内,但显示有HR-HPV感染。可疑的DNA图谱与病变显著相关。在497例接受重复HPV检测的患者中,首次涂片时正常的DNA图谱预测HPV感染清除(敏感性81.5%;特异性45.4%;PPV 69%;阴性预测值62.4%)。在持续性HR-HPV感染中,首次涂片时可疑的DNA图谱将检测经组织学证实的HSIL的PPV从10.8%提高到22.7%,敏感性为95.2%。DNA倍体可用于选择具有HSIL高风险的涂片,尤其是在持续性HR-HPV感染的病例中。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验